Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain

BACKGROUND: Opioid addiction is a worldwide problem. Agonist opioid treatment (AOT) is the most widespread and frequent pharmacotherapeutic approach. Methadone has been the most widely used AOT, but buprenorphine, a partial μ-opiod agonist and a κ-opiod antagonist, is fast gaining acceptance. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Raga, Jose, Gonzalez-Saiz, Francisco, Oñate, Julian, Oyagüez, Itziar, Sabater, Eliazar, Casado, Miguel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402931/
https://www.ncbi.nlm.nih.gov/pubmed/22828157
http://dx.doi.org/10.1186/2191-1991-2-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402931/
https://www.ncbi.nlm.nih.gov/pubmed/22828157
http://dx.doi.org/10.1186/2191-1991-2-3

Ejemplares similares